{
    "nctId": "NCT04009148",
    "briefTitle": "Cascade Testing in Families With Newly Diagnosed Hereditary Breast and Ovarian Cancer Syndrome",
    "officialTitle": "Cascade Testing in Families With Newly Diagnosed Hereditary Breast and Ovarian Cancer Syndrome",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "BRCA-Mutated Ovarian Carcinoma, BRIP1 Gene Mutation, MSH2 A636P, MLH1 Gene Mutation, MSH6 Gene Mutation, PMS2 Gene Mutation, EPCAM, RAD51C Gene Mutation",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 120,
    "primaryOutcomeMeasure": "Establishing the CASCADE Cohort",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* All subjects must have a diagnosis of epithelial ovarian cancer, Fallopian tube caner or primary peritoneal cancer with a known pathogenic genetic mutation.\n* All subjects must agree to participate.\n* All subjects must have first or second degree relatives who have not been diagnosed with the same genetic mutation.\n* A previous diagnosis of cancer in the subject's first or second degree relative is allowed.\n\nExclusion Criteria:\n\n* Subjects whose first and/or second degree relatives have already been tested with the subject's known mutations, and no other viable family members are available for testing.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}